Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D Storage, Release and Tissue Buffering: Full Evidence Review

Previous related pageVitamin D Storage, Release and Tissue Buffering: Study SummaryNext related pageVitamin D Storage, Release and Tissue Buffering: Study Summary
Study at a glance

What was studied?

Four human studies measured vitamin D forms in fat or followed blood and tissue changes over time. A separate mouse study examined uptake into muscle fibers.

What was found?

Vitamin D was measurable in fat. Previous long-term supplementation continued to affect blood levels after it stopped. Modest fat loss did not clearly raise the measured blood marker. Mouse muscle took up 25-hydroxyvitamin D, a substance made from vitamin D, under experimental conditions.

What does it mean?

Tissues can retain vitamin D, but finding it in tissue does not measure how quickly it returns to blood.

What are the limits?

Only small numbers of people provided tissue samples. Some total stores were calculated rather than directly measured. Mouse uptake does not establish human muscle release. These studies do not tell an individual how long their stores will last.

Read the full article below ↓

Vitamin D can be measured in body fat, and previous exposure can continue to influence blood measurements after supplementation stops. Those observations do not tell us exactly how much each tissue releases, how release is controlled, or how long a particular person’s stores will last. This review compares human tissue studies with a mouse muscle experiment to separate demonstrated storage from proposed buffering. For the shorter account, read Vitamin D Storage, Release and Tissue Buffering: Study Summary.

What does “stored vitamin D” mean?

Storage is a question about the location and movement of molecules. Before interpreting a result, it is necessary to identify the substance measured, the tissue sampled and the time interval. Parent vitamin D3, also called cholecalciferol, is not the same substance as 25-hydroxyvitamin D, abbreviated 25(OH)D. Nor is either interchangeable with the active hormone, 1,25-dihydroxyvitamin D. Vitamin D Activation explains the conversion background. A finding about one form cannot automatically be assigned to the others.

Four quantities need separate names. Tissue concentration describes the amount per unit of tissue. Total tissue content also depends on how much tissue there is. Blood concentration describes a circulating sample. Flux describes movement into or out of a compartment over time. A biopsy supplies evidence about concentration; it is not, by itself, a measurement of flux. Similarly, a larger total store need not mean a higher concentration in every gram of fat.

These distinctions matter when interpreting Vitamin D and Body Fat. An association between adiposity and a blood result does not identify a single cause. Tissue uptake, distribution, subsequent metabolism and changing external exposure can all affect the observations a study must explain. The useful question is which of these processes the particular design actually measured, rather than which explanation sounds most intuitive.

Finding parent vitamin D3 in human fat

Blum and colleagues measured parent D3 in abdominal subcutaneous fat from 17 adults undergoing bariatric surgery. Their mass-spectrometry method identified tissue D3, and fat concentrations were associated with serum D3. This is direct evidence of deposits of the parent molecule. It is not evidence that the deposits were being released at a particular rate.

The pilot lacked a normal-weight comparison group and sampled one depot. Participants were a selected surgical population, mostly white women, and blood was obtained before surgery rather than simultaneously with the biopsy. One participant was excluded following recent travel. These features restrict generalisation. The paper also gives inconsistent minimum tissue values in its prose and table, so that range is not reproduced here.

The contribution of such a study is analytical as well as physiological: it establishes what was found in a sample. It cannot independently settle whether fat is an effective reserve during low exposure, whether a particular blood value signifies inadequate tissue availability, or whether weight reduction will increase circulating vitamin D. Those require different observations. Treating an accurate tissue measurement as an answer to all three questions would go beyond the experiment.

Concentration and total amount can tell different stories

Carrelli and colleagues compared adipose tissue from 21 severely obese women and 15 normal-weight women undergoing surgery. They sampled omental and subcutaneous fat and combined tissue assays with body-composition measurements. Between-group differences in absolute tissue concentrations were not statistically clear, whereas modelled total adipose stores were greater in the obese group. Omental concentrations exceeded subcutaneous concentrations significantly within the obese group.

The total-store estimates were calculations, not a complete collection of all body fat. They combined sampled concentrations with regional mass estimates and did not establish the amount in every organ or depot. Supplement use differed between groups; exposure history and missing samples added uncertainty. This independent cohort therefore adds evidence about depot heterogeneity and amount-versus-concentration, without proving equal exchange rates or ruling out sequestration.

A calculation can be useful without being a direct observation. Its interpretation depends on the assumptions joining the measurements. If a small biopsy is used to represent a much larger compartment, the estimate assumes sufficient similarity within that compartment. If another depot is not sampled, its contribution remains uncertain. Reporting the calculated amount as though every store had been directly measured would hide that uncertainty.

Persistence after a long supplementation period

Martinaityte and colleagues followed 76 adults who had previously received vitamin D3 or placebo in a multi-year randomized trial. Blood measurements continued for a year after the intervention. Subcutaneous biopsies were available from 29 participants initially and only 12 at follow-up. Prior supplementation was associated with persistent blood differences and declining adipose vitamin D, supporting a contribution from mobilisable stores.

This was a follow-up of the earlier randomized exposure, not a newly randomized withdrawal experiment. Diet, continued supplement use and unmeasured tissues complicate attribution. It did not directly trace molecules from fat into blood. Reported phases of decline in the excess serum concentration are not molecular tracer half-lives. A companion report from the same parent trial is not an independent replication.

Time strengthens the storage interpretation because observations after exposure ends can address persistence that a single biopsy cannot. Nevertheless, persistence is a net result. A circulating trajectory reflects molecules entering the measured pool and leaving it. Vitamin D Clearance and Degradation provides the complementary elimination context. A slow decline alone cannot allocate the contribution of every tissue or determine whether all participants would show the same pattern under ordinary seasonal conditions.

Does losing fat necessarily raise blood 25(OH)D?

Piccolo and colleagues studied an exploratory subset of 20 adults from a controlled-feeding weight-loss trial. Gluteal biopsies and blood samples were collected over 12 weeks. Although fat mass decreased, changes in tissue 25(OH)D3 concentration and serum total 25(OH)D were not statistically clear. This qualifies the assumption that modest fat loss must produce a measurable increase in blood 25(OH)D.

It does not prove that no molecules were released. Concentration can remain similar while the mass of the compartment changes. Small numbers, dietary differences, season, one sampled depot and different serum/tissue analytes limit inference. Correlations were sensitive to an extreme tissue value. The parent trial randomized dietary conditions; this selected analysis was not a randomized test of vitamin D release itself.

This distinction is important when interpreting a negative result. Failure to detect a blood increase addresses that measured outcome under those conditions. It does not erase chemical storage or demonstrate an immobile compartment. Conversely, an increase in another weight-loss study would not, without further evidence, prove that fat release was its sole cause. The hypothesis concerns a pathway; the blood result is the combined output of several pathways.

Muscle evidence belongs in a different category

Girgis and colleagues used male mice, isolated muscle fibers and cultured cells to examine vitamin D receptor expression and uptake of labelled 25(OH)D. Active-hormone pretreatment increased uptake in normal fibers, while that increment was absent in receptor-knockout fibers. Baseline uptake remained. This supports an experimentally regulated uptake component, not measured release from human muscle.

Small experimental groups, whole-animal knockout effects and differences between cultured cells and mature tissue limit translation. A contemporary commentary by Pike challenged receptor-detection and mechanistic interpretations, including the inference of a rapid signalling route; the authors defended their controls. The disagreement remains relevant. The experiment is distinct from the human cohorts, but a related laboratory programme is not automatically independent human confirmation.

Vitamin D Receptors supplies the receptor background. The methodological distinction is between identifying a possible mechanism and measuring its contribution to an intact person’s vitamin D balance. A cell experiment may be valuable for the former while leaving the latter unanswered. Vitamin D Metabolism at the Cellular Level helps locate this cellular scale within the wider physiology, without converting an experimental uptake effect into a demonstrated human seasonal reserve.

Comparing the evidence without counting votes

The doses below describe research exposures, not personal recommendations. IU means international units. P values describe statistical evidence under a study model; they do not measure effect size or establish clinical importance.

Study and designMeasured resultInterpretation limits
Blum, 2008: 17 bariatric adults; cross-sectional biopsiesMean fat D3 was 102.8 nmol/kg. Fat D3 correlated with serum parent D3 (r = 0.68; P = 0.003).One depot, selected surgical sample; blood preceded biopsy. The correlation concerns parent D3, not serum 25(OH)D or release.
Carrelli, 2017: 21 obese and 15 normal-weight womenMean subcutaneous total vitamin D was 34.2 versus 25.7 ng/g (P = 0.63). Modelled total adipose stores were 2.29 versus 0.44 mg (P = 0.002).D2 plus D3; concentration difference not statistically clear. Total stores were estimated from biopsies and body composition, not collected directly. Control subcutaneous samples numbered 12.
Martinaityte, 2017: 76 adults after 3 to 5 years of weekly D3 or placeboAfter prior 20,000 IU/week D3, mean serum 25(OH)D fell from 121.7 to 84.5 nmol/L over 12 months; previous placebo: 70.9 to 73.1. Median fat vitamin D in the prior-D3 group fell from 209 to 100 ng/g.Only 18 prior-D3 biopsies at baseline and 8 repeated; overall biopsies 29 then 12. Persistence supports mobilisable stores, but no direct fat-to-blood tracing was performed.
Piccolo, 2013: 20 adults; 12-week weight-loss subsetMean fat mass fell from 38.5 to 33.5 kg. Serum total 25(OH)D changed from 33.5 to 38.6 nmol/L and fat 25(OH)D3 from 5.8 to 6.2 nmol/kg; neither vitamin D change was statistically clear.Different blood/tissue analytes and assays; fat analyte detectable in 18 baseline and 19 end samples. A concentration result cannot establish zero release.
Girgis, 2014: male-mouse muscle fibers and cell experimentsActive-hormone pretreatment increased labelled 25(OH)D3 uptake by about 40% in normal fibers (P < 0.005; 3 mice per group). The increment was absent in receptor-knockout fibers.Experimental uptake, not release or human clinical buffering. Baseline uptake persisted; receptor detection and mechanistic interpretation were debated.

These studies are useful together because they observe different parts of the problem. They should not be described as five confirmations of one universal mechanism. The four human cohorts are distinct. The muscle work uses a different model and has a different inference boundary. Agreement that molecules can be present in tissue is a narrower proposition than agreement about their rate of release or their clinical importance.

Vitamin D Transport Proteins provides the carrier-protein context, while Vitamin D in the Body places tissue handling within the body’s wider distribution system. Neither general context nor a shared keyword resolves the missing measurement. To show a particular release mechanism, evidence must distinguish movement from changes in concentration caused by other processes. To establish clinical sufficiency, evidence must also connect availability with the relevant physiological or clinical outcome.

The historical account Distribution and storage of vitamin D and its metabolites in man: Full Study addresses an earlier distribution study. The present comparison adds modern depot measurements, follow-up after prolonged exposure, a weight-loss qualification and experimental muscle uptake. It does not replace the historical study or treat its interpretation as independent verification of the newer observations.

What buffering does and does not establish

In this review, buffering describes the possibility that retained material changes the timing of circulating availability. It is not a promise that stores maintain every required function throughout a period of low intake or sunlight. Those are different propositions and require different endpoints. A blood concentration can remain higher after previous exposure without establishing an optimal target or protection against a later deficiency state.

Storage also cannot be treated as a safety mechanism that makes large doses harmless. The existence of a tissue compartment does not establish an unlimited capacity, predictable release, or protection from excessive exposure. The research regimens in these papers describe experiments; they are not personal dosing schedules. No reserve duration, loading strategy or weight-loss treatment recommendation can be calculated from this selected set.

A stronger human account would connect repeated tissue measurements, contemporaneous blood measurements, quantified exposure and direct tracking of movement. It would also distinguish parent vitamin D from its metabolites and test whether one depot represents another. These are requirements of the inference being sought, not claims that a single perfect experiment has already answered every question.

The supported conclusion is therefore specific. Human adipose tissue contains measurable vitamin D forms; depot composition and total amounts require separate interpretation; prior prolonged exposure can have persistent effects; and modest fat loss does not guarantee a detectable serum rise. Experimental muscle uptake extends the possible tissue mechanisms, but the magnitude and clinical importance of muscle buffering in people remain unresolved.

Source access and scope

This is a selected comparative review, not a systematic meta-analysis. Principal texts and their material tables were assessed for the five studies. Available figure captions and explicit textual results were checked; no unseen-graph estimate is used. Martinaityte’s comparison supplement and Carrelli’s supplementary file were not inspected, so claims relying on them are excluded. Abboud’s related muscle paper remained abstract-only and is not counted. Pike’s commentary and the authors’ response inform the stated uncertainty, not an additional study count.

Scientific references

Vitamin D Stored in Fat Tissue During a 5-Year Intervention Affects Serum 25-Hydroxyvitamin D Levels the Following Year. Martinaityte I et al. JCEM. 2017;102:3731 to 3738. DOI: 10.1210/jc.2017-01187. Publisher full text.

Vitamin D(3) in fat tissue. Blum M et al. Endocrine. 2008;33:90 to 94.

Vitamin D Storage in Adipose Tissue of Obese and Normal Weight Women. Carrelli A et al. J Bone Miner Res. 2017;32:237 to 242.

Association between Subcutaneous White Adipose Tissue and Serum 25-Hydroxyvitamin D in Overweight and Obese Adults. Piccolo BD et al. Nutrients. 2013;5:3352 to 3366.

The Vitamin D Receptor (VDR) Is Expressed in Skeletal Muscle of Male Mice and Modulates 25-Hydroxyvitamin D (25OHD) Uptake in Myofibers. Girgis CM et al. Endocrinology. 2014;155:3227 to 3237.

Expression of the Vitamin D Receptor in Skeletal Muscle: Are We There Yet?. Pike JW. Endocrinology. 2014. Commentary and associated author response; not an additional study.

Related reading

Physiology

Vitamin D Storage

Explains how vitamin D is stored in the body, how storage buffers availability over time, and why stored vitamin D complicates interpretation of blood levels and status.

Read more →

Original sources